The Office of Research Quality at the National Institute of Neurological Disorders and Stroke (NINDS) is issuing this notice to inform the extramural research community about updates to its initiative to develop an educational resource on the principles of rigorous research. The first set of applications have been funded from the Materials to Enhance Training in Experimental Rigor (METER) (UE5 Clinical Trial Not Allowed) funding opportunity, and two more receipt dates remain: October 11, 2022 and October 10, 2023. Because the mission of this initiative is to develop educational units on a variety of principles of rigorous research, NINDS would like to inform the scientific community about principles of rigorous research that remain high priority for potential development into educational units by METER applicants.
Find Funding Opportunities
NIH Extramural Response to Natural Disasters and Other Emergencies
In emergency situations, the NIH’s immediate concern is for the health and safety of people and animals in the programs we oversee. Visit the NIH Extramural Response to Natural Disasters and Other Emergencies web page for biomedical research community resources, including NIH Guide Notices and other information of particular relevance to investigators and their institutions, links to web pages listing NIH’s response to certain major events (past and present); and links to similar web sites from other Federal agencies.
COVID-19 Funding Notices | Approved Initiative Concepts | Research Opportunity Announcements
All NINDS-related notices of funding opportunities (NOFOs), request for applications (RFAs), program announcements (PAs), and other NIH Guide announcements are listed. Search the Closed Opportunities tab to find expired opportunities. Search the Notices tab to find all Notices.
Learn more about award types and program directors and managers.
NINDS has a number of open positions for researchers and clinicians to contribute to exciting neuroscience programs - APPLY NOW!
For more focused results add quotes to indicate parameters. Example format: "search term".
Notice of Information: High-Priority Principles of Rigorous Research for NINDS Materials to Enhance Training in Experimental Rigor (METER) Funding Opportunity
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-23-011
Tuesday, August 9, 2022
Notice Type: NOT
Notice of Correction to Key Dates for RFA-NS-22-040 "BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Not Allowed)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-22-112
Monday, August 8, 2022
Notice Type: NOT
The purpose of this notice is to correct the key dates section of RFA-NS-22-040 "BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Not Allowed)".
Notice of NINR Participation in PAR-22-181, "NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NR-22-016
Thursday, August 4, 2022
Notice Type: NOT
This Notice informs potential applicants of the National Institute of Nursing Research (NINR) participation, effective immediately, in the funding opportunity announcement (FOA) PAR-22-181, NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional).
Notice of Change to the title of PAR-22-181, "NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-22-111
Thursday, August 4, 2022
Notice Type: NOT
The purpose of this notice is to inform applicants of a change to the title to reflect NINR's participation in PAR-22-181 "NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)".
Notice of Correction to Award Conditions for NOT-NS-23-001: "Notice of Special Interest (NOSI): COVID-19 Related Revisions to NINDS ADRD Human Subjects Cooperative Agreement Programs"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-23-020
Tuesday, August 2, 2022
Notice Type: NOT
Correcting total vs direct cost in the text.
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain(RM1 Clinical Trial Optional)
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-23-009
Friday, July 29, 2022
Notice Type: NOT
NOITP
Notice of Correction to Announcement Type for "PAR-22-142: NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-22-120
Thursday, July 28, 2022
Notice Type: NOT
This FOA should be a reissue of PAR-21-236.
Notification to the community of change in maximum salary provided by NINDS K award mechanisms for clinician-scientists.
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-23-005
Wednesday, July 27, 2022
Notice Type: NOT
This notice informs the public that, effective in Fiscal Year 2022 (FY2022), NINDS will raise the maximum salary support provided to clinician-scientists on Career Development (K) awards for the related funding opportunity announcements listed above. The new cap on salary provided for clinician-scientists
supported by individual, mentored K awards (K01, K08, K22, K23, K99) will be $125,000;
supported by individual, independent K awards (K02) will be $150,000;
supported by institutional K awards (K12) will be $115,000.
Notice of Change to the maximum salary for clinician-scientists for PAR-21-153 and PAR-21-234 NINDS faculty Development Award to Promote Diversity in Neuroscience Research (K01)
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-22-107
Tuesday, July 26, 2022
Notice Type: NOT
The purpose of this notice is to inform potential applicants of a change to the maximum salary for clinician scientists for PAR-21-153 "NINDS faculty Development Award to Promote Diversity in Neuroscience Research (K01 Clinical Trial Required)" and PAR-21-234 "NINDS faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)". Effective in FY 2022, NINDS will raise the maximum salary support provided to clinician-scientists on Career Development (K) awards. The new cap on salary provided for clinician-scientists supported by the K01 will be $125,000.00.
Notice of Change to the maximum salary for clinician-scientists for PAR-21-327 and PAR-21-328 Career Transition Award for NINDS Intramural Clinician-Scientists (K22)
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-22-108
Tuesday, July 26, 2022
Notice Type: NOT
The purpose of this notice is to inform potential applicants of a change to the maximum salary for clinician scientists for PAR-21-327 "Career Transition Award for NINDS Intramural Clinician-Scientists (K22 - Clinical Trial Required)" and PAR-21-328 "Career Transition Award for NINDS Intramural Clinician-Scientists (K22 - Clinical Trial Not Allowed)". Effective in FY 2022, NINDS will raise the maximum salary support provided to clinician-scientists on Career Development (K) awards. The new cap on salary provided for clinician-scientists supported by the K01 will be $125,000.00.